BioNxt Solutions Inc.
BNXT
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.32M | -4.09M | -3.88M | -4.77M | -4.74M |
| Total Depreciation and Amortization | 34.00K | 45.80K | 67.10K | 82.40K | 101.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.65M | 1.59M | 1.02M | 1.07M | 987.60K |
| Change in Net Operating Assets | 226.50K | 55.40K | 584.60K | 1.22M | 624.80K |
| Cash from Operations | -2.41M | -2.39M | -2.21M | -2.39M | -3.02M |
| Capital Expenditure | -- | -- | -- | -62.00K | -62.00K |
| Sale of Property, Plant, and Equipment | 59.30K | 99.10K | 41.10K | 263.30K | 263.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 59.30K | 99.10K | 41.10K | 201.30K | 201.30K |
| Total Debt Issued | 5.50M | 5.50M | 2.11M | -- | -- |
| Total Debt Repaid | -2.74M | -1.03M | -1.03M | -9.30K | -18.50K |
| Issuance of Common Stock | 704.40K | 1.22M | 1.85M | 2.66M | 4.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -466.90K | -2.22M | -282.70K | -198.50K | -315.10K |
| Cash from Financing | 2.12M | 2.46M | 1.92M | 1.80M | 2.79M |
| Foreign Exchange rate Adjustments | 1.50K | 1.70K | 1.20K | 2.80K | 900.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -230.40K | 170.30K | -245.00K | -384.30K | -28.10K |